Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas
(Q33759231)
scientific article
scientific article
Language:
Current Data About
Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas